Page 2 - Presenting Cells News Today

Should You Buy or Sell Jasper Therapeutics Stock? Get The Latest JSPR Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

SQZ Biotechnologies (NYSE:SQZ – Get Rating) and Jasper Therapeutics (NASDAQ:JSPR – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership. Profitability This table compares SQZ Biotechnologies and Jasper Therapeutics’ […]

This article describes how a novel approach in cancer treatment targets anti or pro tumoral immune responses. By using TissueFAXS Chroma and StrataQuest analysis key parameters for evaluating prognosis in primary colorectal cancer can be identified.

SQZ Biotechnologies (NYSE:SQZ – Get Rating) has been assigned a consensus rating of “Buy” from the two analysts that are covering the company, MarketBeat reports. Two analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have updated their coverage on the stock in the last year is […]

Investment analysts at Chardan Capital began coverage on shares of SQZ Biotechnologies (NYSE:SQZ – Get Rating) in a research report issued to clients and investors on Wednesday, The Fly reports. The firm set a “buy” rating and a $17.00 price target on the stock. Chardan Capital’s price target suggests a potential upside of 407.46% from […]

Wall Street brokerages expect SQZ Biotechnologies (NYSE:SQZ – Get Rating) to post $4.17 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have provided estimates for SQZ Biotechnologies’ earnings, with estimates ranging from $3.00 million to $4.92 million. SQZ Biotechnologies posted sales of $4.54 million in the same quarter last […]

Wall Street brokerages predict that SQZ Biotechnologies (NYSE:SQZ – Get Rating) will report earnings per share (EPS) of ($0.76) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for SQZ Biotechnologies’ earnings, with the lowest EPS estimate coming in at ($0.82) and the highest estimate coming in at ($0.71). SQZ […]

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) and SQZ Biotechnologies (NYSE:SQZ – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability and risk. Volatility and Risk Adaptive Biotechnologies has a beta of […]

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Wall Street analysts expect that SQZ Biotechnologies (NYSE:SQZ – Get Rating) will announce ($0.71) earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for SQZ Biotechnologies’ earnings, with the highest EPS estimate coming in at ($0.70) and the lowest estimate coming in at ($0.71). SQZ Biotechnologies […]